The stock of Tandem Diabetes Care Inc (TNDM) has gone down by -2.19% for the week, with a -23.53% drop in the past month and a 16.02% rise in the past quarter. The volatility ratio for the week is 4.57%, and the volatility levels for the past 30 days are 4.77% for TNDM. The simple moving average for the past 20 days is -10.47% for TNDM’s stock, with a 35.17% simple moving average for the past 200 days.
Is It Worth Investing in Tandem Diabetes Care Inc (NASDAQ: TNDM) Right Now?
Company’s 36-month beta value is 1.29.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 5 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TNDM is 64.07M, and currently, short sellers hold a 13.74% ratio of that floaft. The average trading volume of TNDM on July 04, 2024 was 1.59M shares.
TNDM) stock’s latest price update
The stock price of Tandem Diabetes Care Inc (NASDAQ: TNDM) has surged by 1.53 when compared to previous closing price of 39.15, but the company has seen a -2.19% decline in its stock price over the last five trading sessions. zacks.com reported 2024-07-02 that Tandem Diabetes Care, Inc. TNDM announced the latest real-world insights from a user satisfaction survey on their Tandem Mobi system during the 84th Scientific Sessions of the American Diabetes Association (“ADA”) in Orlando, FL. Data from the survey demonstrated that Tandem Mobi helps improve the quality of life for patients with type 1 diabetes.
Analysts’ Opinion of TNDM
Many brokerage firms have already submitted their reports for TNDM stocks, with Redburn Atlantic repeating the rating for TNDM by listing it as a “Buy.” The predicted price for TNDM in the upcoming period, according to Redburn Atlantic is $60 based on the research report published on May 30, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see TNDM reach a price target of $57, previously predicting the price at $40. The rating they have provided for TNDM stocks is “Buy” according to the report published on May 22nd, 2024.
Wells Fargo gave a rating of “Overweight” to TNDM, setting the target price at $45 in the report published on April 29th of the current year.
TNDM Trading at -10.07% from the 50-Day Moving Average
After a stumble in the market that brought TNDM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.96% of loss for the given period.
Volatility was left at 4.77%, however, over the last 30 days, the volatility rate increased by 4.57%, as shares sank -22.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.50% upper at present.
During the last 5 trading sessions, TNDM fell by -2.02%, which changed the moving average for the period of 200-days by +83.08% in comparison to the 20-day moving average, which settled at $43.83. In addition, Tandem Diabetes Care Inc saw 34.38% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TNDM starting from Allen Dick, who sale 5,000 shares at the price of $51.68 back on May 30 ’24. After this action, Allen Dick now owns 0 shares of Tandem Diabetes Care Inc, valued at $258,400 using the latest closing price.
Allen Dick, the Director of Tandem Diabetes Care Inc, purchase 5,000 shares at $18.96 during a trade that took place back on Nov 27 ’23, which means that Allen Dick is holding 19,962 shares at $94,778 based on the most recent closing price.
Stock Fundamentals for TNDM
Current profitability levels for the company are sitting at:
- -0.19 for the present operating margin
- 0.49 for the gross margin
The net margin for Tandem Diabetes Care Inc stands at -0.18. The total capital return value is set at -0.2. Equity return is now at value -48.62, with -14.93 for asset returns.
Based on Tandem Diabetes Care Inc (TNDM), the company’s capital structure generated 0.6 points at debt to capital in total, while cash flow to debt ratio is standing at -0.06. The debt to equity ratio resting at 1.5. The interest coverage ratio of the stock is 164.72.
Currently, EBITDA for the company is -118.22 million with net debt to EBITDA at -3.37. When we switch over and look at the enterprise to sales, we see a ratio of 3.88. The receivables turnover for the company is 8.28for trailing twelve months and the total asset turnover is 0.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.81.
Conclusion
In a nutshell, Tandem Diabetes Care Inc (TNDM) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
